Welcome to ATS 2018, the intellectual crossroads of pulmonary, critical care, and sleep medicine!
May 20, 2018
Connect With Colleagues at Networking Events
Expanding your knowledge and network are primary objectives of the ATS 2018 International Conference, where you will find world-class educational programming as well as numerous opportunities for networking.
Bibbins-Domingo to Discuss Communities at Risk
The annual ATS Diversity Forum’s featured speaker is Kirsten Bibbins-Domingo, MD, PhD, MAS, who will address career and diversity issues followed by a question-and-answer period.
Earn MOC Points and CME Credits
ATS 2018 attendees are able to earn up to 44.5 American Board of Internal Medicine MOC Medical Knowledge points and 10 American Board of Pediatrics Part 2 MOC
Self-Assessment points.
Tuberculosis Still Threatens Public Health Worldwide
For decades, health officials have set their sites on eradicating tuberculosis. Although the number of active TB cases has decreased in the United States and other developed countries, it remains widespread around the world. In fact, TB has regained the inglorious distinction of being the infectious disease that kills more people than any other, according to Kevin Fennelly, MD, MPH, chair of the ATS Assembly on Pulmonary Infections and TB.
From Spanish Flu to Ebola
Viruses evolve principally to survive and propagate. Killing the host is not part of that survival plan. When viruses go rogue, bad things happen. In talking about rogue viruses, Joshua Lederberg, the microbial geneticist and Nobel Laureate, said, “The single biggest threat to man’s continued dominance on the planet is the virus.”
New ATS Executive Director
ATS has a new executive director. Karen Collishaw, MPP, a highly experienced medical association leader, joined the ATS at the end of April after a national search. She succeeds Stephen C. Crane, PhD, MPH, who has served as ATS executive director since 2007 and is retiring.
Debunking Medical Myths
Exciting advances in iPS cell differentiation and ex vivo lung tissue bioengineering are gaining new attention as potential therapies for lung disease and transplantation.
Proteins Could be Key to Rare Lung Disorders
Pediatric rare lung diseases, including disorders such as childhood interstitial and diffuse lung diseases primary ciliary dyskinesia, and lung involvement in systemic juvenile inflammatory arthritis, are associated with high morbidity and are often life-threatening. These disorders are poorly understood, under-recognized, and have limited evidence-based therapeutic options.
Sunday Awards Session Honors Four Recipients
Four renowned physicians and researchers will be honored during Sunday’s Awards Session, featuring the Amberson Lecture and the presentation of the Trudeau Medal and two Distinguished Achievement Awards.